Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat and Capecitabine in High-Risk Breast Cancer
NCT03473639Phase 1Completed
- Sponsor
- University of Virginia
- Start
- Jan 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of entinostat in breast cancer, sponsored by University of Virginia. Started Jan 2019; status: completed.
02
Drugs
entinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03473639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03473639.